✦ LIBER ✦

Celecoxib most cost-effective choice in high-risk arthritis patients

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coxibs not cost-effective for arthritis

✍ Roxanne Nelson 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 55 KB

SES cost effective in high-risk patients

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Acarbose cost effective in high-risk pat

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 121 KB

The cost effectiveness of rofecoxib and

✍ Maetzel, Andreas ;Krahn, Murray ;Naglie, Gary 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

Paclitaxel-eluting stent cost effective

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 137 KB

Ramipril cost effective in patients at h

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 125 KB